Search

Displaying results 8761 - 8770 of 10000 in total
  1. Drug

    Thebacon

    go.drugbank.com/drugs/DB13458
    Experimental

    Categories: Cough and Cold Preparations, Opium Alkaloids and Derivatives
  2. Drug

    BGB-DXP593

    go.drugbank.com/drugs/DB16357
    Investigational

    the clinical trial NCT04551898 (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)) by

  3. Drug

    Arginine glutamate

    go.drugbank.com/drugs/DB13207
    Investigational

    Categories: Bile and Liver Therapy, Alimentary Tract and Metabolism
  4. Drug

    Propenidazole

    go.drugbank.com/drugs/DB13319
    Experimental

    Categories: Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics
  5. Drug

    GZ-389988

    go.drugbank.com/drugs/DB16056
    Investigational

    GZ-389988 is under investigation in clinical trial NCT02845271 (Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients

  6. Drug

    Recainam

    go.drugbank.com/drugs/DB20085
    Experimental

    The usage of the INN stem '-cain-' in the name indicates that Recainam is a class I antiarrhythmic, procainamide and lidocaine derivative. Recainam has a monoisotopic molecular weight of 263.2 Da.

  7. Drug

    Milacainide

    go.drugbank.com/drugs/DB20252
    Experimental

    The usage of the INN stem '-cain-' in the name indicates that Milacainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  8. Drug

    Bucainide

    go.drugbank.com/drugs/DB20650
    Experimental

    The usage of the INN stem '-cain-' in the name indicates that Bucainide is a class I antiarrhythmic, procainamide and lidocaine derivative. Bucainide has a monoisotopic molecular weight of 329.28 Da.

  9. Drug

    COCAINE ESTERASE (RBP-8000)

    go.drugbank.com/drugs/DB19225
    Investigational

    RBP-8000 is under investigation in clinical trials (A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse) for the treatment of Cocaine Abuse.

    Categories: Enzymes and Coenzymes, Amino Acids, Peptides, and Proteins
  10. Drug

    KB002

    go.drugbank.com/drugs/DB05194
    Experimental

    KB002 is an engineered human IgG1k antibody engineered human. It is developed for the treatment of autoimmune diseases, initially rheumatoid arthritis.